FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280493018> ?p ?o ?g. }

• W4280493018 endingPage "3179" @default.
• W4280493018 startingPage "3159" @default.
• W4280493018 abstract "MET exon 14 skipping in patients with advanced non-small cell lung cancer (aNSCLC), can be targeted with MET inhibitors including tepotinib, capmatinib, savolitinib, and crizotinib. Matching-adjusted indirect comparison (MAIC) methodology was used to compare outcomes data between agents and to address bias from differences in baseline characteristics.Patient-level data from the VISION study (tepotinib) were weighted for comparison with aggregate data from the GEOMETRY mono-1 (capmatinib), NCT02897479 (savolitinib) and PROFILE 1001 (crizotinib) studies in patients with aNSCLC, using baseline characteristics prognostic for overall survival (OS) in VISION. Overall response rate (ORR), OS, progression-free survival (PFS), and duration of response (DOR) were compared. Patients were stratified by line of therapy: overall (all lines), previously treated, and treatment-naïve.Improvements in ORR and all time-to-event endpoints were predicted for tepotinib compared with crizotinib and savolitinib in the different populations, although comparisons with savolitinib were hindered by considerable differences in baseline patient populations. Tepotinib appeared to be associated with prolonged PFS and OS compared with capmatinib in previously treated patients (PFS HR 0.54; 95% CI 0.36-0.83; OS HR 0.66; 95% CI 0.42-1.06) and the overall populations (PFS HR 0.60; 95% CI 0.43-0.86; OS HR 0.72; 95% CI 0.49-1.05), with smaller improvements in DOR. The ORR comparisons between tepotinib and capmatinib identified a swing of up to ± 6 percentage points in the weighted tepotinib ORR depending on the population studied (treatment-naïve vs. previously treated patients).The MAIC identified potential differences in efficacy endpoints with the different MET inhibitors, and predicted prolonged PFS and OS with tepotinib compared with capmatinib and crizotinib. Although MAIC cannot balance for unobserved factors, it remains an informative method to contextualize single-arm studies, where head-to-head trials are unlikely to be feasible." @default.
• W4280493018 created "2022-05-22" @default.
• W4280493018 creator A5001058762 @default.
• W4280493018 creator A5016565734 @default.
• W4280493018 creator A5061243953 @default.
• W4280493018 creator A5083256847 @default.
• W4280493018 creator A5083292431 @default.
• W4280493018 date "2022-05-11" @default.
• W4280493018 modified "2023-10-05" @default.
• W4280493018 title "Matching-Adjusted Indirect Comparison (MAIC) of Tepotinib with Other MET Inhibitors for the Treatment of Advanced NSCLC with MET Exon 14 Skipping Mutations" @default.
• W4280493018 cites W1982967337 @default.
• W4280493018 cites W2011129617 @default.
• W4280493018 cites W2092901728 @default.
• W4280493018 cites W2134787029 @default.
• W4280493018 cites W2560174513 @default.
• W4280493018 cites W2650689221 @default.
• W4280493018 cites W2778073518 @default.
• W4280493018 cites W3000668520 @default.
• W4280493018 cites W3031018272 @default.
• W4280493018 cites W3042002926 @default.
• W4280493018 cites W3082015854 @default.
• W4280493018 cites W3107022845 @default.
• W4280493018 cites W3120246130 @default.
• W4280493018 cites W3140948903 @default.
• W4280493018 cites W3153812142 @default.
• W4280493018 cites W3168281894 @default.
• W4280493018 cites W3175096644 @default.
• W4280493018 cites W3179656848 @default.
• W4280493018 cites W3197722986 @default.
• W4280493018 cites W3202399737 @default.
• W4280493018 cites W3206982798 @default.
• W4280493018 cites W4200475329 @default.
• W4280493018 cites W4220957917 @default.
• W4280493018 doi "https://doi.org/10.1007/s12325-022-02163-9" @default.
• W4280493018 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35543963" @default.
• W4280493018 hasPublicationYear "2022" @default.
• W4280493018 type Work @default.
• W4280493018 citedByCount "4" @default.
• W4280493018 countsByYear W42804930182023 @default.
• W4280493018 crossrefType "journal-article" @default.
• W4280493018 hasAuthorship W4280493018A5001058762 @default.
• W4280493018 hasAuthorship W4280493018A5016565734 @default.
• W4280493018 hasAuthorship W4280493018A5061243953 @default.
• W4280493018 hasAuthorship W4280493018A5083256847 @default.
• W4280493018 hasAuthorship W4280493018A5083292431 @default.
• W4280493018 hasBestOaLocation W42804930181 @default.
• W4280493018 hasConcept C126322002 @default.
• W4280493018 hasConcept C143998085 @default.
• W4280493018 hasConcept C2776232967 @default.
• W4280493018 hasConcept C2776256026 @default.
• W4280493018 hasConcept C2779422266 @default.
• W4280493018 hasConcept C71924100 @default.
• W4280493018 hasConceptScore W4280493018C126322002 @default.
• W4280493018 hasConceptScore W4280493018C143998085 @default.
• W4280493018 hasConceptScore W4280493018C2776232967 @default.
• W4280493018 hasConceptScore W4280493018C2776256026 @default.
• W4280493018 hasConceptScore W4280493018C2779422266 @default.
• W4280493018 hasConceptScore W4280493018C71924100 @default.
• W4280493018 hasIssue "7" @default.
• W4280493018 hasLocation W42804930181 @default.
• W4280493018 hasLocation W42804930182 @default.
• W4280493018 hasLocation W42804930183 @default.
• W4280493018 hasLocation W42804930184 @default.
• W4280493018 hasLocation W42804930185 @default.
• W4280493018 hasOpenAccess W4280493018 @default.
• W4280493018 hasPrimaryLocation W42804930181 @default.
• W4280493018 hasRelatedWork W2148832193 @default.
• W4280493018 hasRelatedWork W2390152934 @default.
• W4280493018 hasRelatedWork W2400744927 @default.
• W4280493018 hasRelatedWork W2516942920 @default.
• W4280493018 hasRelatedWork W2742779675 @default.
• W4280493018 hasRelatedWork W2940751250 @default.
• W4280493018 hasRelatedWork W2941535758 @default.
• W4280493018 hasRelatedWork W3039972379 @default.
• W4280493018 hasRelatedWork W3197633853 @default.
• W4280493018 hasRelatedWork W4380151320 @default.
• W4280493018 hasVolume "39" @default.
• W4280493018 isParatext "false" @default.
• W4280493018 isRetracted "false" @default.
• W4280493018 workType "article" @default.